Person

Hooman Hakami

Formerly EVP & Group President Diabetes, Medtronic

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$23.1M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • MDT
    Medtronic
    EVP & Group President Diabetes
    Aug 2016 – last filing Sep 2019

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Sep 10, 2019MDTSale10,000$107.09$1.1M
Sep 10, 2019MDTSale423$107.22$45K
Sep 10, 2019MDTSale10,257$107.31$1.1M
Sep 10, 2019MDTSale321$107.22$34K
Sep 10, 2019MDTSale27,254$107.28$2.9M
Sep 10, 2019MDTSale852$107.22$91K
Sep 10, 2019MDTSale19,054$107.41$2.0M
Sep 10, 2019MDTSale595$107.22$64K
Sep 10, 2019MDTSale14,121$107.41$1.5M
Jun 12, 2019MDTSale31,731$97.49$3.1M
Jun 12, 2019MDTSale20,933$97.49$2.0M
Aug 31, 2018MDTSale26,159$96.29$2.5M
Jan 5, 2018MDTSale26,158$85.00$2.2M
Mar 2, 2017MDTSale52,316$82.33$4.3M

SEC reporting-owner ID (CIK) 1610035 · all filings on EDGAR